- |||||||||| leucovorin calcium / Generic mfg.
Trial primary completion date: A Folinic Acid Intervention for Autism Spectrum Disorders (clinicaltrials.gov) - Apr 1, 2016 P2, N=99, Terminated, Not yet recruiting --> Recruiting | Initiation date: Dec 2015 --> Mar 2016 Trial primary completion date: Jun 2015 --> Nov 2015
- |||||||||| TheraSphere (yttrium 90 microspheres) / Boston Scientific
Trial completion: Phase II Trial Evaluating OS With Therasphere (clinicaltrials.gov) - Mar 18, 2016 P2, N=9, Completed, N=280 --> 380 Active, not recruiting --> Completed
- |||||||||| sapitinib (AZD8931) / AstraZeneca
Trial primary completion date, Combination therapy: PANTHER: Phase I/II Trial of Antagonism of HER in GI Cancer (clinicaltrials.gov) - Mar 16, 2016 P1/2, N=24, Recruiting, Not yet recruiting --> Active, not recruiting Trial primary completion date: Feb 2016 --> Jun 2016
- |||||||||| Teysuno (gimeracil/oteracil/tegafur) / Nordic Group, Otsuka
Enrollment closed, Trial primary completion date, Metastases: Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer (clinicaltrials.gov) - Mar 7, 2016 P2, N=228, Active, not recruiting, N=50 --> 0 | Recruiting --> Withdrawn Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Aug 2016
- |||||||||| Avastin (bevacizumab) / Roche
Enrollment closed, Enrollment change, Trial primary completion date, Surgery, Metastases: Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer (clinicaltrials.gov) - Mar 5, 2016 P2, N=20, Active, not recruiting, Trial primary completion date: Jul 2014 --> Jul 2016 Recruiting --> Active, not recruiting | N=39 --> 20 | Trial primary completion date: Dec 2015 --> Oct 2014
- |||||||||| Mektovi (binimetinib) / Ono Pharma, Pierre Fabre, Pfizer
Enrollment closed, Combination therapy, Metastases: MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer (clinicaltrials.gov) - Mar 4, 2016 P1, N=34, Active, not recruiting, Recruiting --> Active, not recruiting | N=39 --> 20 | Trial primary completion date: Dec 2015 --> Oct 2014 Recruiting --> Active, not recruiting
- |||||||||| LY2090314 / Eli Lilly
Enrollment change, Trial termination, Trial primary completion date, Metastases, Biopsy: A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer (clinicaltrials.gov) - Feb 26, 2016 P1/2, N=13, Terminated, Active, not recruiting --> Completed | Trial primary completion date: Aug 2016 --> Feb 2016 N=45 --> 13 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2019 --> Jun 2015; Study has been terminated due to slow enrollment.
|